메뉴 건너뛰기




Volumn 10, Issue 1, 2009, Pages 34-37

Prokinetic drugs in the intensive care unit: Reviewing the evidence

Author keywords

erythromycin; gastrointestinal motility; intensive care; metoclopramide; prokinetics

Indexed keywords


EID: 84916213840     PISSN: 17506352     EISSN: 17506360     Source Type: Journal    
DOI: 10.1177/175114370901000110     Document Type: Review
Times cited : (18)

References (37)
  • 1
    • 0032914757 scopus 로고    scopus 로고
    • Early enteral nutritional support improves outcome: Hypothesis or fact?
    • Zaloga GP. Early enteral nutritional support improves outcome: hypothesis or fact?. Crit Care Med. 1999 ; 27: 259-61
    • (1999) Crit Care Med , vol.27 , pp. 259-261
    • Zaloga, G.P.1
  • 2
    • 0037972384 scopus 로고    scopus 로고
    • Prokinetic agents in critical care
    • Doherty WL, Winter B. Prokinetic agents in critical care. Crit Care. 2003 ; 7: 206-08
    • (2003) Crit Care , vol.7 , pp. 206-208
    • Doherty, W.L.1    Winter, B.2
  • 3
    • 0036276576 scopus 로고    scopus 로고
    • Gastric prokinetic motility therapy to facilitate early enteral nutrition in the intensive care unit
    • Miskovitz P. Gastric prokinetic motility therapy to facilitate early enteral nutrition in the intensive care unit. Crit Care Med. 2002 ; 30: 1386-87
    • (2002) Crit Care Med , vol.30 , pp. 1386-1387
    • Miskovitz, P.1
  • 4
    • 0036189001 scopus 로고    scopus 로고
    • Is enteral feeding for everyone?
    • Maykel J, Bistrian BR. Is enteral feeding for everyone?. Crit Care Med. 2002 ; 30: 714-16
    • (2002) Crit Care Med , vol.30 , pp. 714-716
    • Maykel, J.1    Bistrian, B.R.2
  • 5
    • 34247370872 scopus 로고    scopus 로고
    • The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: Benefits versus risks
    • Hawkyard CV, Koerner RJ. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother. 2007 ; 59: 347-58
    • (2007) J Antimicrob Chemother , vol.59 , pp. 347-358
    • Hawkyard, C.V.1    Koerner, R.J.2
  • 6
    • 0036317489 scopus 로고    scopus 로고
    • Gastrointestinal promotility drugs in the critical care setting: A systematic review of the evidence
    • Booth CM, Heyland DK, Paterson WG. Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence. Crit Care Med. 2002 ; 30: 1429-35
    • (2002) Crit Care Med , vol.30 , pp. 1429-1435
    • Booth, C.M.1    Heyland, D.K.2    Paterson, W.G.3
  • 7
    • 33847260157 scopus 로고    scopus 로고
    • Gastrointestinal motility and prokinetics in the critically ill
    • Chapman MJ, Nyugen NQ, Fraser RJ. Gastrointestinal motility and prokinetics in the critically ill. Curr Opin Crit Care. 2007 ; 13: 187-94
    • (2007) Curr Opin Crit Care , vol.13 , pp. 187-194
    • Chapman, M.J.1    Nyugen, N.Q.2    Fraser, R.J.3
  • 8
    • 0034036624 scopus 로고    scopus 로고
    • Metoclopramide for preventing pneumonia in critically ill patients receiving enteral tube feeding: A randomised controlled trial
    • Yavagal DR, Karnad DR, Oak JL. Metoclopramide for preventing pneumonia in critically ill patients receiving enteral tube feeding: a randomised controlled trial. Crit Care Med. 2000 ; 28: 1408-11
    • (2000) Crit Care Med , vol.28 , pp. 1408-1411
    • Yavagal, D.R.1    Karnad, D.R.2    Oak, J.L.3
  • 9
    • 0033008277 scopus 로고    scopus 로고
    • Metoclopramide improves gastric motility in critically ill patients
    • Jooste CA, Mustoe J, Collee G. Metoclopramide improves gastric motility in critically ill patients. Intensive Care Med. 1999 ; 25: 464-68
    • (1999) Intensive Care Med , vol.25 , pp. 464-468
    • Jooste, C.A.1    Mustoe, J.2    Collee, G.3
  • 10
    • 0001318312 scopus 로고    scopus 로고
    • Gastric emptying in critically ill patients: A randomised, blinded, prospective comparison of metoclopramide with placebo
    • Calcroft RM, Joynt G, Hung V. Gastric emptying in critically ill patients: a randomised, blinded, prospective comparison of metoclopramide with placebo. Intensive Care Med. 1997 ; 23: S138
    • (1997) Intensive Care Med , vol.23 , pp. 138
    • Calcroft, R.M.1    Joynt, G.2    Hung, V.3
  • 11
    • 0035209341 scopus 로고    scopus 로고
    • Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically ill, mechanically ventilated adults
    • Maclaren R, Ward DP, Hall RI, et al. Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically ill, mechanically ventilated adults. Clin Therapeut. 2001 ; 23: 1855-66
    • (2001) Clin Therapeut , vol.23 , pp. 1855-1866
    • Maclaren, R.1    Ward, D.P.2    Hall, R.I.3
  • 12
    • 0036317693 scopus 로고    scopus 로고
    • Promoting enteral feeding 101
    • Tisherman SA, Marik P. Promoting enteral feeding 101. Crit Care Med. 2002 ; 30: 1653-54
    • (2002) Crit Care Med , vol.30 , pp. 1653-1654
    • Tisherman, S.A.1    Marik, P.2
  • 13
    • 0029124805 scopus 로고
    • Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: A double-blind, randomized, placebo-controlled study
    • Dive A, Galanti C, Jamart J, et al. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study. Crit Care Med. 1995 ; 23: 1356-62
    • (1995) Crit Care Med , vol.23 , pp. 1356-1362
    • Dive, A.1    Galanti, C.2    Jamart, J.3
  • 14
    • 0033854173 scopus 로고    scopus 로고
    • Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding
    • Chapman MJ, Fraser RJ, Kluger MT, et al. Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Crit Care Med. 2000 ; 28: 2334-37
    • (2000) Crit Care Med , vol.28 , pp. 2334-2337
    • Chapman, M.J.1    Fraser, R.J.2    Kluger, M.T.3
  • 15
    • 0036272992 scopus 로고    scopus 로고
    • Erythromycin and early enteral nutrition in mechanically ventilated patients
    • Reignier J, Bensaid S, Perrin-Gachadoat D, et al. Erythromycin and early enteral nutrition in mechanically ventilated patients. Crit Care Med. 2002 ; 30: 1237-41
    • (2002) Crit Care Med , vol.30 , pp. 1237-1241
    • Reignier, J.1    Bensaid, S.2    Perrin-Gachadoat, D.3
  • 16
    • 0036739183 scopus 로고    scopus 로고
    • Erythromycin reduces delayed gastric emptying in critically ill trauma patients: A randomized, controlled trial
    • Berne JD, Norwood, Scott H, et al. Erythromycin reduces delayed gastric emptying in critically ill trauma patients: a randomized, controlled trial. J Trauma. 2002 ; 53: 422-25
    • (2002) J Trauma , vol.53 , pp. 422-425
    • Berne, J.D.1    Norwood2    Scott, H.3
  • 17
    • 0034006727 scopus 로고    scopus 로고
    • Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: A randomized, placebo-controlled, crossover study
    • MacLaren R, Kuhl DA, Gervasio JM, et al. Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: a randomized, placebo-controlled, crossover study. Crit Care Med. 2000 ; 28: 438-44
    • (2000) Crit Care Med , vol.28 , pp. 438-444
    • Maclaren, R.1    Kuhl, D.A.2    Gervasio, J.M.3
  • 18
    • 21744440255 scopus 로고    scopus 로고
    • Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill
    • Ritz MA, Chapman MJ, Fraser R, et al. Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill. Intensive Care Med. 2005 ; 31: 949-54
    • (2005) Intensive Care Med , vol.31 , pp. 949-954
    • Ritz, M.A.1    Chapman, M.J.2    Fraser, R.3
  • 19
    • 33846419791 scopus 로고    scopus 로고
    • How should we use prokinetic drugs in patients who are intolerant to enteral feeding?
    • Asai T. How should we use prokinetic drugs in patients who are intolerant to enteral feeding?. Crit Care Med. 2007 ; 35: 483-89
    • (2007) Crit Care Med , vol.35 , pp. 483-489
    • Asai, T.1
  • 20
    • 37549049069 scopus 로고    scopus 로고
    • Prokinetic therapy for feed intolerance in critical illness: One drug or two?
    • Nguyen NQ, Chapman M, Fraser R, et al. Prokinetic therapy for feed intolerance in critical illness: one drug or two?. Crit Care Med. 2007 ; 35: 2561-57
    • (2007) Crit Care Med , vol.35 , pp. 2561-2657
    • Nguyen, N.Q.1    Chapman, M.2    Fraser, R.3
  • 21
    • 84916236920 scopus 로고    scopus 로고
    • Prokinetics effect on gastric emptying in critically ill ventilated patients measured by the C13 breath test with a novel device
    • Hersch M, Krasilnikov V, Einav S, et al. Prokinetics effect on gastric emptying in critically ill ventilated patients measured by the C13 breath test with a novel device. Crit Care. 2007 ; 11: 146-47
    • (2007) Crit Care , vol.11 , pp. 146-147
    • Hersch, M.1    Krasilnikov, V.2    Einav, S.3
  • 22
    • 33846453647 scopus 로고    scopus 로고
    • Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness
    • Nyugen NQ, Chapman MJ, Fraser RJ, et al. Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Crit Care Med. 2007 ; 35: 483-89
    • (2007) Crit Care Med , vol.35 , pp. 483-489
    • Nyugen, N.Q.1    Chapman, M.J.2    Fraser, R.J.3
  • 23
    • 34447579278 scopus 로고    scopus 로고
    • Erythromycin for prokinesis: Imprudent prescribing?
    • Dall'Antonia M, Wilks M, Coen PG, et al. Erythromycin for prokinesis: imprudent prescribing?. Crit Care. 2006 ; 10: 112
    • (2006) Crit Care , vol.10 , pp. 112
    • Dall'Antonia, M.1    Wilks, M.2    Coen, P.G.3
  • 24
    • 38149098381 scopus 로고    scopus 로고
    • Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance
    • Nguyen NQ, Ching K, Fraser R, et al. Risk of Clostridium difficile diarrhoea in critically ill patients treated with erythromycin-based prokinetic therapy for feed intolerance. Intensive Care Med. 2008 ; 34: 169-74
    • (2008) Intensive Care Med , vol.34 , pp. 169-174
    • Nguyen, N.Q.1    Ching, K.2    Fraser, R.3
  • 26
    • 34547767088 scopus 로고    scopus 로고
    • A clinical audit of the efficacy of tegaserod as a prokinetic agent in the intensive care unit
    • Stephens D P. A clinical audit of the efficacy of tegaserod as a prokinetic agent in the intensive care unit. Crit Care Resuscitation. 2007 ; 9: 148-50
    • (2007) Crit Care Resuscitation , vol.9 , pp. 148-150
    • Stephens, D.P.1
  • 27
    • 16844364043 scopus 로고    scopus 로고
    • Effect of CCK-1 antagonist, dexloxiglumide in female patients with irritable bowel syndrome: A pharmacodynamic and pharmacogenomic study
    • Cremonin F, Camilleri M, McKinzie S, et al. Effect of CCK-1 antagonist, dexloxiglumide in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study. Am J Gastroenterology. 2005 ; 100: 652-63
    • (2005) Am J Gastroenterology , vol.100 , pp. 652-663
    • Cremonin, F.1    Camilleri, M.2    McKinzie, S.3
  • 28
    • 23844433696 scopus 로고    scopus 로고
    • Gastrokinetic effect of ghrelin analog RC-1139 in the rat: Effect on post-operative and on morphine induced ileus
    • Poitras P, Polvino WJ, Rocheleau B. Gastrokinetic effect of ghrelin analog RC-1139 in the rat: Effect on post-operative and on morphine induced ileus. Peptides. 2005 ; 26: 1598-601
    • (2005) Peptides , vol.26 , pp. 1598-1601
    • Poitras, P.1    Polvino, W.J.2    Rocheleau, B.3
  • 29
    • 0034873597 scopus 로고    scopus 로고
    • What comes after macrolides and other motilin stimulants?
    • Tack J, Peeters T. What comes after macrolides and other motilin stimulants?. Gut. 2001 ; 49: 317-18
    • (2001) Gut , vol.49 , pp. 317-318
    • Tack, J.1    Peeters, T.2
  • 30
    • 20144366569 scopus 로고    scopus 로고
    • Alvimopan: An oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction - A 21-day treatment-randomized clinical trial
    • Paulson DM, Kennedy DT, Donovick RA, et al. Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction - a 21-day treatment-randomized clinical trial. J Pain. 2005 ; 6: 184-92
    • (2005) J Pain , vol.6 , pp. 184-192
    • Paulson, D.M.1    Kennedy, D.T.2    Donovick, R.A.3
  • 31
    • 35348905618 scopus 로고    scopus 로고
    • Alvimopan: A peripheral acting μ-opioid-receptor antagonist used for the treatment of postoperative ileus
    • Balsama L, Weese J. Alvimopan: a peripheral acting μ-opioid-receptor antagonist used for the treatment of postoperative ileus. Therapy. 2007 ; 4: 653-64
    • (2007) Therapy , vol.4 , pp. 653-664
    • Balsama, L.1    Weese, J.2
  • 32
    • 33746050728 scopus 로고    scopus 로고
    • Use of novel prokinetic agents to facilitate return of gastrointestinal motility in adult critically ill patients
    • Roberts DJ, Banh HL, Hall RI. Use of novel prokinetic agents to facilitate return of gastrointestinal motility in adult critically ill patients. Curr Opin Crit Care. 2006 ; 12: 295-302
    • (2006) Curr Opin Crit Care , vol.12 , pp. 295-302
    • Roberts, D.J.1    Banh, H.L.2    Hall, R.I.3
  • 33
    • 0242509223 scopus 로고    scopus 로고
    • Gastric emptying in mechanically ventilated critically ill patients: Effect of neuromuscular blocking agent
    • Tamion F, Hamelin K, Duflo A, et al. Gastric emptying in mechanically ventilated critically ill patients: effect of neuromuscular blocking agent. Intensive Care Med. 2003 ; 29: 1717-22
    • (2003) Intensive Care Med , vol.29 , pp. 1717-1722
    • Tamion, F.1    Hamelin, K.2    Duflo, A.3
  • 34
    • 0042279261 scopus 로고    scopus 로고
    • Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients
    • Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN. 2003 ; 27: 355-73
    • (2003) JPEN , vol.27 , pp. 355-373
    • Heyland, D.K.1    Dhaliwal, R.2    Drover, J.W.3
  • 35
    • 38349061821 scopus 로고    scopus 로고
    • Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition
    • Landzinski J, Kiser T, Fish D, et al. Gastric motility function in critically ill patients tolerant vs intolerant to gastric nutrition. JPEN. 2008 ; 32: 45-50
    • (2008) JPEN , vol.32 , pp. 45-50
    • Landzinski, J.1    Kiser, T.2    Fish, D.3
  • 36
    • 42949108574 scopus 로고    scopus 로고
    • The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illness
    • Nguyen NQ, Chapman M, Fraser R, et al. The effects of sedation on gastric emptying and intra-gastric meal distribution in critical illness. Intensive Care Med. 2008 ; 34: 454-60
    • (2008) Intensive Care Med , vol.34 , pp. 454-460
    • Nguyen, N.Q.1    Chapman, M.2    Fraser, R.3
  • 37
    • 25444433609 scopus 로고    scopus 로고
    • Critical care dysmotility: Abnormal foregut motor function in the ICU/ITU patient
    • Quigley EMM. Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient. Gut. 2005 ; 54: 1351-52
    • (2005) Gut , vol.54 , pp. 1351-1352
    • Quigley, E.M.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.